Industry Insights
-
How Can Real-World Data Benefit Your Trials?
3/12/2024
Clinical trial data is being supplemented with real-world data (RWD) gathered from a variety of sources. Dive deeper into this emerging trend to understand its implications for the future of clinical research.
-
4 Takeaways From Building A Differentiated Franchise In Clinical Immunology
3/12/2024
Immunovant CEO Pete Salzmann, MD, MBA, shares what he and his young company have learned about developing the right workforce, selecting viable targets, listening to patient needs, and trying alternative trial designs.
-
It Might Be Time To Move On From Your Legacy EDC
3/11/2024
The tools and technologies we rely on to capture and manage clinical trial data are evolving at a rapid pace. Discover how modern EDC solutions are revolutionizing the world of clinical research data management.
-
Duchenne Muscular Dystrophy - Global Clinical Trial Landscape (2024)
3/11/2024
Explore how this comprehensive approach can offer hope for improved outcomes and quality of life for DMD patients, highlighting global commitment to tackling this complex disorder.
-
Rheumatoid Arthritis – Global Clinical Trial Landscape
3/11/2024
While RA presents a substantial global health challenge, see how evolving therapies and research efforts offer hope for improved outcomes and better management of this debilitating condition.
-
Global Prevalence And Clinical Trials Landscape Of DMD
3/11/2024
Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.
-
Eliminating Travel As A Top Barrier To Clinical Trial Participation
3/8/2024
Participant travel is an area consistently cited as a leading barrier to participation. Here, the author highlights several examples of unique challenges encountered by participants and how Greenphire worked to eliminate them.
-
Navigating China's Biologics Approval And Accelerated Pathways
3/8/2024
Pharma companies doing business in China have four key routes to register drugs faster than the standard ways. This discussion breaks down accelerated pathways and offers tips on how to approach them.
-
Community-Driven Registries Drive Understanding Of Rare Diseases
3/8/2024
In an effort to increase and diversify research, the Pulmonary Fibrosis Foundation (PFF) envisioned a new approach to aggregating usable medical data — asking patients directly.
-
2023 Site Payments And Budgeting Market Trends Survey
3/7/2024
Explore the findings from this survey of the global clinical trials market, shedding light on processes, challenges, and preferences associated with global site payments, and more.